Dr. Bill Smith, [10/29/2021 9:48 AM]
[Forwarded from Leaky Vaccine]
COVID ADE 'Trojan Horse' Mechanism Confirmed - but not Disease Enhancing
Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcgRIIA and FcgRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages | American Society for Microbiology (2021)
(
https://t.me/LeakyVax/756)This study evaluated ADE of infection using COVID-19 convalescent-phase plasma and BHK cells expressing human Fcg receptors (FcgRs) and found that FcgRIIA and FcgRIIIA mediated modest ADE of infection against SARS-CoV-2. Although ADE of infection was observed in monocyte-derived macrophages infected with SARS-CoV-2, including its variants, proinflammatory cytokine/chemokine expression was not upregulated in macrophages. SARS-CoV-2 infection thus produces antibodies that elicit ADE of infection, but these antibodies do not contribute to excess cytokine production by macrophages.
Although this study shows in this instance this mechanism does not appear to be disease enhancing, it is unforgivably callous and enormously short-sighted that this unknown and uncharacterized risk was and continues to be forced on the public. The article continues:
"These results indicate that neutralization may occur with plasma containing sufficient neutralizing antibodies but that ADE-inducing antibodies may function at lower concentrations than neutralizing antibodies. Given that recent studies have shown that neutralizing antibodies against SARS-CoV-2 S protein can exist for up to 8 months, ADE-inducing antibodies may not elicit ADE of infection for several months." "Our knowledge of antibody populations and duration in COVID-19 vaccine recipients remains limited." "These studies suggest that the antibodies produced in response to the vaccines that were developed based on early strains of SARS-CoV-2 could elicit ADE of infection for recent variants, including B.1.617.2. Additional studies are needed to evaluate how long ADE-inducing and neutralizing antibodies exist in vaccine recipients."
Participants in vaccine trials and vaccine-recipients have so far been completely uninformed of the specific risk that COVID-19 vaccines could worsen disease upon exposure to circulating virus, these ethical concerns were raised and published months ago in October 2020 during trials:
"Vaccines for SARS, MERS and RSV have never been approved, and the data generated in the development and testing of these vaccines suggest a serious mechanistic concern: that these vaccines ... may worsen COVID-19 disease via antibody-dependent enhancement (ADE)." "The specific and significant COVID-19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, ..."
Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease | International Journal of Clinical Practice (2021)
(
https://t.me/LeakyVax/553)Related posts:
Robert Malone on "Vaccine-Enhanced Infection"
(
https://t.me/LeakyVax/732)16 Vaccine Mechanisms with Uncertain Consequences
(
https://t.me/LeakyVax/705)The Competitive Advantage of Exploiting Immunity
(
https://t.me/LeakyVax/694)Antibody-Dependant Enhancement Resources
(
https://t.me/LeakyVax/184)Circulating immune complexes drive immunopathology in COVID-19 | bioRxiv (2021) (
https://t.me/LeakyVax/678) #Devolution #Expand Your Thinking #Eye of The Storm #TheGreatAwakening